D. Bodurka

发表

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.

E. Winer, R. Wahl, S. Edge, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concurrent Chemoradiation in the Routine Management of Patients With Cervical Cancer: Does Marital Status Matter?

D. Bodurka, L. Ramondetta, H. Thames, 2009, International Journal of Gynecologic Cancer.

Effects of music relaxation video on pain and anxiety for women with gynaecological cancer receiving intracavitary brachytherapy: a randomised controlled trial

J. Mcfarlane, D. Bodurka, R. Coleman, 2015 .

Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum.

D. Bodurka, A. Malpica, M. Deavers, 2008, Gynecologic oncology.

Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.

A. Sood, D. Bodurka, A. Malpica, 2009, Gynecologic oncology.

Undifferentiated Carcinoma of the Endometrium

D. Bodurka, R. Broaddus, A. Malpica, 2005, The American journal of surgical pathology.

Association of Low-Grade Endometrioid Carcinoma of the Uterus and Ovary With Undifferentiated Carcinoma: A New Type of Dedifferentiated Carcinoma?

D. Bodurka, A. Malpica, M. Deavers, 2006, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Willingness of pregnant women to vaccinate themselves and their newborns with the HPV vaccine.

D. Bodurka, M. Frey, B. Slomovitz, 2011, Vaccine.

Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA).

D. Bodurka, P. Thaker, J. Wolf, 2009, Cancer treatment reviews.

Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients.

Anil K Sood, Michael T Deavers, A. Sood, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum.

D. Bodurka, A. Malpica, R. Iyer, 2012, Gynecologic oncology.

Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations.

D. Bodurka, H. Macdonald, R. Sutphen, 2011, Gynecologic oncology.

Diagnosis and Management of Stage II Endometrial Cancer

D. Bodurka, R. Previs, 2015 .

Prospective Study of Symptom Assessment Among Patients With Cervical Cancer During Concurrent Chemoradiotherapy With Weekly Cisplatin or Every-3-Week Cisplatin and 5-Fluorouracil

D. Bodurka, Charlotte C. Sun, A. Jhingran, 2013, International Journal of Gynecologic Cancer.

Cost‐Effectiveness Analysis of Diagnosis and Management of Cervical Squamous Intraepithelial Lesions

R. Richards-Kortum, D. Bodurka, S. Cantor, 1998, Obstetrics and gynecology.

Quality of life for patients with epithelial ovarian cancer

D. Bodurka, P. Ramirez, Charlotte C. Sun, 2007, Nature Clinical Practice Oncology.

Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation

G. Hortobagyi, D. Bodurka, F. Meric-Bernstam, 2009, Cancer.

Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome

D. Bodurka, F. Meric-Bernstam, B. Arun, 2008, BMC Cancer.

Exploring the effect of PAs on physician trainee learning: An interview study

D. Bodurka, D. Dolmans, A. Eid, 2019, JAAPA : official journal of the American Academy of Physician Assistants.

Lifestyle Modification in Cervical Cancer Survivors: An Ongoing Need

D. Bodurka, M. Schlumbrecht, Charlotte C. Sun, 2014, International Journal of Gynecologic Cancer.

Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer

D. Bodurka, L. Ramondetta, S. Giordano, 2017, International Journal of Gynecologic Cancer.

Surgical education and training program development for gynecologic oncology: American perspective.

D. Bodurka, M. Hoffman, 2009, Gynecologic oncology.

Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer

D. Bodurka, R. Coleman, B. Slomovitz, 2020, International Journal of Gynecological Cancer.

Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix.

D. Bodurka, Jubilee Brown, L. Ramondetta, 2005, Gynecologic oncology.

Fighting cancer together: Development and implementation of shared medical appointments to standardize and improve chemotherapy education.

D. Bodurka, M. Lozano, C. Levenback, 2016, Gynecologic oncology.

Handoff Tool Enabling Standardized Transitions Between the Emergency Department and the Hospitalist Inpatient Service at a Major Cancer Center

D. Bodurka, T. Rice, S. Banala, 2018, American journal of medical quality : the official journal of the American College of Medical Quality.

Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer.

D. Bodurka, R. Broaddus, B. Slomovitz, 2004, Journal of the American College of Surgeons.

Does Tamoxifen Use Affect Prognosis in Breast Cancer Patients Who Develop Endometrial Cancer?

D. Bodurka, K. Lu, B. Slomovitz, 2004, Obstetrics and gynecology.

Quality of life in cervix cancer survivors--what matters the most in the long-term?

D. Bodurka, Charlotte C. Sun, M. Frumovitz, 2005, Gynecologic oncology.

Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer.

D. Bodurka, J. Wharton, J. Wolf, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I I T rial o f I rinotecan i n P atients W ith M etastatic Epithelial O varian C ancer o r P eritoneal C ancer

D. Bodurka, J. Wharton, J. Wolf, 2003 .

Training Current and Future Leaders

D. Bodurka, Jolyn S. Taylor, 2017 .

Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer.

A. Sood, D. Bodurka, R. Broaddus, 2007, Gynecologic oncology.

Choosing Wisely: Decreasing the incidence of perioperative blood transfusions in gynecologic oncology.

D. Bodurka, P. Ramirez, K. Schmeler, 2017, Gynecologic oncology.

Prophylactic Bilateral Salpingo-Oophorectomy Compared With Surveillance in Women With BRCA Mutations

D. Bodurka, B. Arun, K. Lu, 2006, Obstetrics and gynecology.

Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.

D. Bodurka, D. Miller, J. Schorge, 2008, Gynecologic oncology.

Lifestyle Modification in Cervical Cancer Survivors: An Ongoing Need

D. Bodurka, M. Schlumbrecht, Charlotte C. Sun, 2011, International Journal of Gynecologic Cancer.

Gynecologic cancer survivorship management

D. Bodurka, S. Westin, Charlotte C. Sun, 2015 .

Caring for cancer patients in the future: a perfect storm on the horizon?

D. Bodurka, Charlotte C. Sun, Marilyn Huang, 2010, Oncology.

Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?

E. Boerwinkle, D. Bodurka, M. Deavers, 2011, Gynecologic oncology.

How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients.

D. Bodurka, L. Ramondetta, Ning Zhang, 2018, Gynecologic oncology.

Dying well: How equal is end of life care among gynecologic oncology patients?

D. Bodurka, L. Ramondetta, Charlotte C. Sun, 2016, Gynecologic oncology.

A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer.

D. Bodurka, L. Ramondetta, M. Deavers, 2004, Gynecologic oncology.

Pelvic fractures after radiotherapy for cervical cancer

A. Sood, D. Bodurka, R. Iyer, 2010, Cancer.

Malignant Diseases of the Vagina

D. Bodurka, M. Frumovitz, 2013 .

Ethics Consultation on a Gynecologic Oncology Service: An Opportunity for Physician Education

D. Bodurka, L. Ramondetta, M. Schlumbrecht, 2011, Journal of Cancer Education.

Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology Center.

E. Bruera, D. Bodurka, S. Westin, 2019, Journal of oncology practice.

End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer.

D. Bodurka, L. Ramondetta, Ning Zhang, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Does Death Anxiety Affect End-of-Life Care Discussions?

D. Bodurka, L. Ramondetta, M. Shen, 2014, International Journal of Gynecologic Cancer.

Missed opportunities: Patterns of medical care and hospice utilization among ovarian cancer patients.

D. Bodurka, L. Ramondetta, Charlotte C. Sun, 2014, Gynecologic oncology.

Use of social media to conduct a cross-sectional epidemiologic and quality of life survey of patients with neuroendocrine carcinoma of the cervix: a feasibility study.

D. Bodurka, Jubilee Brown, L. Ramondetta, 2014, Gynecologic oncology.

A Phase I Trial of Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Patients with Advanced Gynecologic and Breast Malignancies

D. Bodurka, R. Kurzrock, F. Janku, 2011, Clinical Cancer Research.

How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology.

D. Bodurka, M. Munsell, D. Lairson, 2016, Cancer treatment reviews.

Perioperative blood transfusion in gynecologic oncology surgery: analysis of the National Surgical Quality Improvement Program Database.

D. Bodurka, M. Munsell, Charlotte C. Sun, 2015, Gynecologic oncology.

Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation

D. Bodurka, J. Wharton, J. Wolf, 2004, Bone Marrow Transplantation.

Approaches for end‐of‐life care in the field of gynecologic oncology: an exploratory study

D. Bodurka, L. Ramondetta, K. Basen-Engquist, 2004, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Trends among gynecologic oncology inpatient deaths: is end-of-life care improving?

D. Bodurka, J. Wolf, D. Gershenson, 2002, Gynecologic oncology.

Quality of life and gynecologic malignancies

D. Bodurka, Charlotte C. Sun, M. Frumovitz, 2005, Current oncology reports.

Longitudinal quality of life in medically underserved women with locally advanced cervical cancer

D. Bodurka, L. Ramondetta, J. Gallegos, 2012 .

Women's cancer survivorship: time to gear up!

D. Bodurka, V. V. von Gruenigen, 2012, Gynecologic oncology.

A longitudinal evaluation of sexual functioning and quality of life in cervical cancer survivors

D. Bodurka, L. Ramondetta, L. Schover, 2011 .

Sexual function after gynecologic cancer.

D. Bodurka, Charlotte C. Sun, 2006, Obstetrics and gynecology clinics of North America.

Phase I clinical trials in 85 patients with gynecologic cancer: the M. D. Anderson Cancer Center experience.

D. Bodurka, R. Kurzrock, A. Naing, 2010, Gynecologic oncology.

Clinicodemographic factors influencing outcomes in patients with low‐grade serous ovarian carcinoma

D. Bodurka, R. Broaddus, M. Schlumbrecht, 2011, Cancer.

Significantly Greater Expression of ER, PR, and ECAD in Advanced-Stage Low-Grade Ovarian Serous Carcinoma as Revealed by Immunohistochemical Analysis

D. Bodurka, K. Wong, A. Malpica, 2007, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Laparoscopic training and practice in gynecologic oncology among Society of Gynecologic Oncologists members and fellows-in-training.

D. Bodurka, J. Wolf, P. Ramirez, 2004, Gynecologic oncology.

Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy.

D. Bodurka, A. Malpica, J. Wolf, 2003, Gynecologic oncology.

A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium.

D. Bodurka, Jubilee Brown, L. Ramondetta, 2013, Gynecologic oncology.

Response and Survival in Patients With Progressive or Recurrent Serous Ovarian Tumors of Low Malignant Potential

D. Bodurka, M. Deavers, K. Lu, 2002, Obstetrics and gynecology.

Endovascular management of ureteral-iliac artery fistulae with Wallgraft endoprostheses.

C. Wood, D. Bodurka, D. Madoff, 2002, Gynecologic oncology.

Predictors of sexual functioning in ovarian cancer patients.

D. Bodurka, K. Basen-Engquist, E. Shinn, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

What Is the Real Rate of Surgical Site Infection?

D. Bodurka, A. Nick, T. Aloia, 2016, Journal of oncology practice.

Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation.

D. Bodurka, N. Ueno, K. Lu, 2005, Haematologica.

Quality of Life and Sexual Functioning

D. Bodurka, Charlotte C. Sun, 2006 .

Eating disorders among selected female student populations at UCLA.

J. Yager, D. Bodurka, J. Landsverk, 1989, Journal of the American Dietetic Association.

Targeting those with decreased meaning and peace: a supportive care opportunity

D. Bodurka, L. Ramondetta, P. Thaker, 2015, Supportive Care in Cancer.

Approaches for end-of-life care in the field of gynecologic oncology: an exploratory study

D. Bodurka, L. Ramondetta, K. Basen-Engquist, 2004, International Journal of Gynecologic Cancer.

Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research and Treatment EORTC-55971 Cohort

D. Bodurka, I. Vergote, R. Coleman, 2022, International Journal of Gynecological Cancer.

Sarcomatoid carcinoma of the cervix.

D. Bodurka, Jubilee Brown, R. Broaddus, 2003, Gynecologic oncology.

Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?

D. Bodurka, M. Munsell, E. Rubenstein, 2002, Gynecologic oncology.

Growth suppression of human ovarian cancer cell lines by the introduction of a p16 gene via a recombinant adenovirus.

D. Bodurka, J. Wharton, J. Wolf, 1999, Gynecologic oncology.

Uterine Epithelioid Leiomyosarcomas With Clear Cells: Reactivity With HMB-45 and the Concept of PEComa

D. Bodurka, A. Malpica, M. Deavers, 2004, The American journal of surgical pathology.

Low-grade serous primary peritoneal carcinoma.

D. Bodurka, A. Malpica, M. Deavers, 2010, Gynecologic oncology.

Vacuum-assisted closure in the treatment of gynecologic oncology wound failures.

D. Bodurka, J. Wolf, P. Ramirez, 2004, Gynecologic oncology.

An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies.

G. Hortobagyi, D. Bodurka, K. Basen-Engquist, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer.

Xianglin L. Du, D. Bodurka, S. Fang, 2008, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Quality of life and sexual functioning in cervical cancer survivors.

D. Bodurka, L. Schover, M. Munsell, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoplastic Diseases of the Vulva

D. Bodurka, M. Frumovitz, 2007 .

Expression of c‐ABL, c‐KIT, and platelet‐derived growth factor receptor‐β in ovarian serous carcinoma and normal ovarian surface epithelium

D. Bodurka, R. Broaddus, A. Malpica, 2003, Cancer.

The DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology

D. Bodurka, M. Munsell, D. Lairson, 2017, Annals of Surgical Oncology.

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers.

D. Bodurka, R. Broaddus, R. Coleman, 2006, Gynecologic oncology.

A uterine leiomyosarcoma that became positive for HMB45 in the metastasis.

D. Bodurka, Elvio G. Silva, A. Ayala, 2005, Annals of diagnostic pathology.

Grading Ovarian Serous Carcinoma Using a Two-Tier System

Michael T Deavers, Anais Malpica, D. Bodurka, 2004, The American journal of surgical pathology.

Targeting Aurora Kinase with MK-0457 Inhibits Ovarian Cancer Growth

Liz Y. Han, A. Sood, D. Bodurka, 2008, Clinical Cancer Research.

Overexpression of the Centrosomal Protein Aurora-A Kinase is Associated with Poor Prognosis in Epithelial Ovarian Cancer Patients

A. Sood, D. Bodurka, C. Landen, 2007, Clinical Cancer Research.

A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer.

D. Alberts, D. Bodurka, U. Matulonis, 2006, Gynecologic oncology.

Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum.

D. Bodurka, A. Malpica, R. Coleman, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor.

D. Bodurka, K. Wong, A. Malpica, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program.

D. Bodurka, R. Kurzrock, F. Janku, 2014, Anticancer research.

Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.

Deborah Schrag, Craig C Earle, C. Earle, 2006, Journal of the National Cancer Institute.

Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis.

D. Bodurka, Matthew L. Anderson, A. Malpica, 2009, Gynecologic oncology.

Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device.

D. Bodurka, R. Broaddus, L. Ramondetta, 2017, Obstetrics and gynecology.

Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer

D. Bodurka, S. Fang, C. Sun, 2007, International Journal of Gynecologic Cancer.

Obstetric and Gynecologic Emergencies in Cancer Patients

D. Bodurka, M. Schlumbrecht, 2016 .

Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.

D. Bodurka, P. Ramirez, Charlotte C. Sun, 2004, Gynecologic oncology.

Encouraging responses with bevacizumab in recurrent low-grade serous ovarian cancer.

A. Sood, D. Bodurka, A. Malpica, 2010 .

Clinical Behavior of Stage II-IV Low-Grade Serous Carcinoma of the Ovary

A. Sood, D. Bodurka, A. Malpica, 2006, Obstetrics and gynecology.

A phase II trial of oral capecitabine in patients with platinum--and taxane--refractory ovarian, fallopian tube, or peritoneal cancer.

D. Bodurka, C. Verschraegen, J. Wolf, 2006, Gynecologic oncology.

Personalized care in uterine cancer.

D. Bodurka, D. Iglesias, 2012, Clinical advances in hematology & oncology : H&O.

Preeclampsia Prediction and Management Obstetrics and Gynecology International Preeclampsia Prediction and Management

S. Kane, K. Nicolaides, L. Kornman, 2014 .

What's new in gynecology and obstetrics.

D. Bodurka, 2005, Journal of the American College of Surgeons.

Cervical cancer

Suzanne M. Miller, D. Bodurka, L. Schover, 2003, Cancer.

Long‐term survival among 5‐year survivors of adolescent and young adult cancer

Jian Wang, M. Hildebrandt, J. McQuade, 2020, Cancer.

Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study.

R. Wenham, D. Mutch, D. Bodurka, 2018, Gynecologic oncology.

Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer.

D. Bodurka, H. Thames, A. Jhingran, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

C o r r elation o f S moking H istory a nd O ther P atient Characteristics W ith M ajor C omplications o f P elvic Radiation T herapy f or C ervical C ancer

D. Bodurka, H. Thames, A. Jhingran, 2002 .

Reclassification of serous ovarian carcinoma by a 2‐tier system

R. Ozols, M. Birrer, A. Sood, 2012, Cancer.

Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma.

D. Bodurka, A. Malpica, M. Deavers, 2007, Gynecologic oncology.

Predictors of final histology in patients with endometrial cancer.

D. Bodurka, M. Frumovitz, I. Wertheim, 2004, Gynecologic oncology.

Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome.

D. Bodurka, R. Broaddus, K. Lu, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Overall survival after pelvic exenteration for gynecologic malignancy.

D. Bodurka, L. Ramondetta, B. Fellman, 2014, Gynecologic oncology.

Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure.

D. Bodurka, M. Deavers, S. Frank, 2007, Gynecologic oncology.

Alveolar soft part sarcoma of the cervix: case report and literature review

D. Bodurka, Matthew L. Anderson, S. Guntupalli, 2009, Archives of Gynecology and Obstetrics.

beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma.

M. Hung, D. Bodurka, W. Xia, 2003, Gynecologic oncology.

Defining the impact of the use of granulocyte colony stimulating factors on the incidence of chemotherapy-induced neutropenia in patients with gynecologic malignancies

D. Bodurka, Caimiao Wei, Judith A. Smith, 2017, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration.

D. Bodurka, L. Ramondetta, S. Westin, 2018, Gynecologic oncology.

Successful catheter-directed venous thrombolysis in phlegmasia cerulea dolens.

D. Bodurka, M. Wallace, J. Wolf, 2007, Gynecologic oncology.

Risk perception, worry, and test acceptance in average-risk women who undergo ovarian cancer screening.

R. Bast, S. Skates, D. Bodurka, 2014, American journal of obstetrics and gynecology.

Unverifiable Accomplishments and Publications on Applications for Gynecologic Oncology Fellowships

A. Sood, D. Bodurka, Charlotte C. Sun, 2012, Obstetrics and gynecology.

Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment.

Patricia J Eifel, Anuja Jhingran, Charles F Levenback, 2008, International journal of radiation oncology, biology, physics.

Women's preferences for cancer risk management strategies in Lynch syndrome.

D. Bodurka, K. Lu, S. Peterson, 2019, Gynecologic oncology.

Social-cognitive theory predictors of exercise behavior in endometrial cancer survivors.

D. Bodurka, Jubilee Brown, A. Waters, 2013, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

An Integrated Approach to Selecting a Prepared Medical Decision Maker.

E. Bruera, D. Bodurka, S. Westin, 2020, Journal of pain and symptom management.

Room for improvement: An examination of advance care planning documentation among gynecologic oncology patients.

D. Bodurka, L. Ramondetta, M. Shen, 2016, Gynecologic oncology.

Quality of Life in the Gynecologic Cancer Patient

D. Bodurka, K. Basen-Engquist, Charlotte C. Sun, 2004 .

Physical activity and obesity in endometrial cancer survivors: associations with pain, fatigue, and physical functioning.

D. Bodurka, L. Ramondetta, K. Basen-Engquist, 2009, American journal of obstetrics and gynecology.

Generalizability of cancer clinical trial results

B Nebiyou Bekele, D. Bodurka, L. Elting, 2006, Cancer.

A Not So Perfect Score: Factors Associated with the Rate of Straight Line Scoring in Oncology Training Programs

A. Jazaeri, D. Bodurka, D. Urbauer, 2020, Journal of Cancer Education.

Medical and psychosocial issues in gynecologic cancer survivors

D. Bodurka, K. Basen-Engquist, 2007 .

Satisfaction with ovarian carcinoma risk‐reduction strategies among women at high risk for breast and ovarian carcinoma

D. Bodurka, B. Arun, K. Lu, 2011, Cancer.

Survival after intestinal perforation: can it be predicted?

D. Bodurka, M. Schlumbrecht, C. Tung, 2009, Gynecologic oncology.

Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer

D. Bodurka, E. Rubenstein, J. Wharton, 2005, Supportive Care in Cancer.

Nothing left to chance? The impact of locus of control on physical and mental quality of life in terminal cancer patients

E. Bruera, D. Bodurka, L. Ramondetta, 2017, Supportive Care in Cancer.

Feeling powerless: Locus of control as a potential target for supportive care interventions to increase quality of life and decrease anxiety in ovarian cancer patients.

D. Bodurka, L. Ramondetta, P. Thaker, 2015, Gynecologic oncology.

What is the real rate of surgical-site infection?

D. Bodurka, A. Nick, T. Aloia, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Are women ready for the HPV vaccine?

D. Bodurka, Heidi C. Pearson, K. Lu, 2006, Gynecologic oncology.

Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial Cancer.

D. Bodurka, R. Broaddus, L. Ramondetta, 2020, American journal of obstetrics and gynecology.

Symptom research in gynecologic oncology: a review of available measurement tools.

D. Bodurka, S. Agarwal, 2010, Gynecologic oncology.

Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer.

E. Bruera, D. Bodurka, L. Ramondetta, 2015, Gynecologic oncology.

Survivors of gynecologic malignancies: impact of treatment on health and well-being

D. Bodurka, K. Lu, D. Urbauer, 2008, Journal of Cancer Survivorship.

A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.

M. Gore, D. Bodurka, U. Matulonis, 2014, Gynecologic oncology.

HPV vaccine: Breaking down the barriers

D. Bodurka, B. Slomovitz, 2007 .

Patient Preferences for Side Effects Associated With Cervical Cancer Treatment

D. Bodurka, L. Ramondetta, Charlotte C. Sun, 2014, International Journal of Gynecologic Cancer.

E-motions: email for written emotional expression.

E. Bruera, D. Bodurka, F. Strasser, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

E-motions: email for written emotional expression.

E. Bruera, D. Bodurka, F. Strasser, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer.

C. Cleeland, T. Mendoza, D. Bodurka, 2013, Gynecologic oncology.

Human papillomavirus vaccine acceptability: is multimedia education ready for prime time?

D. Bodurka, M. Schlumbrecht, 2010, Gynecologic oncology.

Comparison of four brief depression screening instruments in ovarian cancer patients: Diagnostic accuracy using traditional versus alternative cutpoints.

D. Bodurka, K. Basen-Engquist, C. Carmack, 2017, Gynecologic oncology.

Gynecologic cancer survivor preferences for long-term surveillance

D. Bodurka, A. Milbourne, M. Schlumbrecht, 2018, BMC Cancer.

Dasatinib, paclitaxel, and carboplatin in women with advanced-stage or recurrent endometrial cancer: A pilot clinical and translational study.

P. Ram, A. Sood, D. Bodurka, 2021, Gynecologic oncology.

HPV vaccination practices among American Indian/Alaska Native providers

D. Bodurka, A. Bruegl, J. N. Bottsford-Miller, 2016 .

Laparoscopy training in gynecologic oncology fellowship programs.

D. Bodurka, P. Ramirez, M. Frumovitz, 2008, Gynecologic oncology.

Associations with worry about dying and hopelessness in ambulatory ovarian cancer patients

A. Sood, D. Bodurka, K. Basen-Engquist, 2009, Palliative and Supportive Care.

Factors influencing fertility-sparing treatment for gynecologic malignancies: A survey of Society of Gynecologic Oncology members.

D. Bodurka, Charlotte C. Sun, G. Chisholm, 2017, Gynecologic oncology.

Thoracotomy for the management of recurrent vaginal leiomyosarcoma.

D. Bodurka, M. Anderson, 2008, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Mentorship and productivity among gynecologic oncology fellows.

D. Bodurka, L. Ramondetta, J. Wolf, 2003, Journal of cancer education : the official journal of the American Association for Cancer Education.

Pathologic distribution at the time of interval tumor reductive surgery informs personalized surgery for high-grade ovarian cancer

A. Sood, D. Bodurka, R. Broaddus, 2020, International Journal of Gynecological Cancer.

Implementation of a standardized electronic tool improves compliance, accuracy, and efficiency of trainee‐to‐trainee patient care handoffs after complex general surgical oncology procedures

D. Bodurka, J. Skibber, T. Aloia, 2017, Surgery.

Capturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer.

C. Cleeland, D. Bodurka, Charlotte C. Sun, 2013, Journal of pain and symptom management.

ArticlesEffect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients

C. Earle, E. Trimble, D. Bodurka, 2006 .